100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
56-41-7Enalapril Impurity 2
● In Stock
| Catalogue No.: | VL1360012 |
|---|---|
| CAS No.: | 56-41-7 |
| Mol. Formula: | C₃H₇NO₂ |
| Mol. Weight: | 89.09 g/mol |
Additional information on CAS 56-41-7
Parent drug
EnalaprilIUPAC Name
(2S)-2-Aminopropanoic AcidSynonyms
L-Alanine; (2S)-2-Aminopropanoic Acid;(S)-(+)-Alanine; (S)-2-Aminopropanoic Acid; Lactamine; α-Alanine; (2S)-2-Aminopropanoic Acid; (S)-(+)-Alanine; (S)-2-Aminopropanoic Acid; (S)-Alanine; L-(+)-Alanine; L-2-Aminopropanoic Acid; L-2-Aminopropionic Acid; L-?-Alanine; L-?-Aminopropionic Acid; Lactamine; NSC 206315; ?-Alanine; ?-Aminopropionic Acid;Description
Also known as L-Alanine, (2S)-2-Aminopropanoic Acid, (S)-(+)-Alanine, (S)-2-Aminopropanoic Acid, Lactamine, α-Alanine or (2S)-2-Aminopropanoic Acid. Enalapril is a prodrug that is hydrolyzed after absorption to form the active angiotensin-converting enzyme Enalaprilat. It is administered orally. It decreases blood pressure by lowering peripheral resistance without increasing heart rate. It is well tolerated and safe.References
Todd, Peter A., and Karen L. Goa. “Enalapril.†Drugs, vol. 43, no. 3, Mar. 1992, pp. 346–81, https://doi.org/10.2165/00003495-199243030-00005. ?Davies, Richard O., et al. “Enalapril Worldwide Experience.†The American Journal of Medicine, vol. 77, no. 2, Aug. 1984, pp. 23–35, https://doi.org/10.1016/s0002-9343(84)80055-8. ?Request a Quote
"*" indicates required fields
Other products related to Enalapril impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
